Non-Interventional Clinical Study to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia, Treated With Atypical Antipsychotics.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2011
At a glance
- Drugs Antipsychotics; Quetiapine
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 13 Oct 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2010 Actual initiation date changed from Jan 2009 to Feb 2009 as reported by ClinicalTrials.gov.